0 |
7.5 [136] |
0.1 |
5% |
120 |
|
2 |
Not obtained |
0.1 |
5% |
Not obtained |
Start of interstitial
glucose monitoring |
4 |
6.4 [115] |
0.2 |
10% |
120 |
Increased dextrose after central
line placement |
6 |
3.0 [54] |
0.2 |
10% |
Not obtained |
0.5 mL/kg dextrose
bolus |
8 |
3.3 [60] |
0.2 |
12.5% |
Not obtained |
|
10 |
4.1 [74] |
0.1 |
12.5% |
60 |
Norepinephrine CRI initiated;
furosemide bolus delivered |
12 |
3.6 [64] |
0.1 |
15% |
80 |
Return to blood glucose
monitoring |
14 |
5.2 [94] |
0.1 |
15% |
100 |
|
16 |
5.3 [95] |
0.1 |
15% |
100 |
|
18 |
4.9 [88] |
0.5 |
15% |
110 |
Norepinephrine
discontinued |
20 |
Not obtained |
0.5 |
20% |
Not obtained |
|
22 |
1.9 [34] |
0.5 |
20% |
130 |
Hypoglycemic seizure, 0.5 mL/kg
dextrose bolus, discontinued insulin |
24 |
6.4 [116] |
– |
20% |
130 |
Furosemide CRI
started |
26 |
9.7 [174] |
– |
20% |
115 |
Dextrose
discontinued |